G Birgegard, M Bjorkholm, J Kutti, G Larfars, E Lofvenberg, B Markevarn, M Merup, J Palmblad, N Mauritzson, J Westin and J Samuelsson (2004) “Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders”, Haematologica. Pavia, Italy, 89(5), pp. 520-527. Available at: https://haematologica.org/article/view/3073 (Accessed: 15September2026).